RELX PLC PLC
As of Oct 22, 2026, RELX is in Stage 2, the uptrend phase, now in week 6 (since Sep 14, 2026). It closed at $40.62, 10.8% below its 52-week high and above its 200-day average, which is falling.
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Setup-score rank among Stage 2 peers: #1 of 16 in Specialty Business Services · #1 of 152 in Industrials
Is RELX early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
RELX among Specialty Business Services25th of 46 by relative strength
All 46 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | BUUU | Stage 2 · wk 21 | 99 | +2.0% |
| 2 | TH | Stage 2 · wk 5 | 94 | −34.2% |
| 3 | TISI | Stage 2 · wk 12 | 93 | −15.6% |
| 4 | QUAD | Stage 2 · wk 42 | 92 | +5.3% |
| 5 | UNF | Stage 3 · wk 4 | 90 | +8.3% |
| 6 | CASS | Stage 3 · wk 1 | 88 | +6.7% |
| 7 | FA | Stage 3 · wk 3 | 86 | +6.1% |
| 8 | RHLD | Stage 4 · wk 6 | 86 | −5.4% |
| …25 | RELX | Stage 2 · wk 6 | 47 | +22.3% |
RELX: quick answers
What stage is RELX in?
As of Oct 22, 2026, RELX (RELX) is in Stage 2, the uptrend phase. It entered Stage 2 on Sep 14, 2026 and is in week 6. What the four stages mean
Is RELX in an uptrend?
Yes. RELX is in a Stage 2 uptrend. It trades 19.1% above its 200-day average, which is falling.
How far is RELX from its 52-week high?
RELX closed at $40.62 on Oct 22, 2026, 10.8% below its 52-week high of $45.54. Its 52-week low is $26.99.
How has RELX performed over the past year?
As of Oct 22, 2026, RELX is down 9.8% over the past year and up 4.9% so far in 2026.
Which sector and industry is RELX in?
RELX is in the Specialty Business Services industry, part of the Industrials sector.
About this companyIndustrials· Specialty Business Services
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk, as well as a portfolio of commercial healthcare products. Its Scientific, Technical & Medical segment provides scientific and medical information and data sets for science and healthcare. The Legal segment provides legal, regulatory, and business information and analytics. Its Exhibitions segment combines digital tools and data to help customers connect in-person and online, discover new markets, source products, generate leads, and transact. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.